Literature DB >> 24900798

Selective EP4 Antagonist May Be Useful in Treating Arthritis and Arthritic Pain.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2014        PMID： 24900798      PMCID： PMC4027780          DOI： 10.1021/ml5000367

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  Prostaglandin EP4 antagonists.

Authors:  Manuela Borriello; Luigi Piero Stasi
Journal:  Pharm Pat Anal       Date:  2013-05

Review 2.  The role of prostaglandin E2 in human vascular inflammation.

Authors:  I Gomez; N Foudi; D Longrois; X Norel
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-06-04       Impact factor: 4.006

Review 3.  E-type prostanoid receptor 4 (EP4) in disease and therapy.

Authors:  Viktoria Konya; Gunther Marsche; Rufina Schuligoi; Akos Heinemann
Journal:  Pharmacol Ther       Date:  2013-03-21       Impact factor: 12.310
  3 in total
  3 in total

1.  L161982 alleviates collagen-induced arthritis in mice by increasing Treg cells and down-regulating Interleukin-17 and monocyte-chemoattractant protein-1 levels.

Authors:  Liang Chen; Xianglei Wu; Jun Zhong; Dongqing Li
Journal:  BMC Musculoskelet Disord       Date:  2017-11-16       Impact factor: 2.362

2.  Aberrant subchondral osteoblastic metabolism modifies NaV1.8 for osteoarthritis.

Authors:  Jianxi Zhu; Gehua Zhen; Senbo An; Xiao Wang; Mei Wan; Yusheng Li; Zhiyong Chen; Yun Guan; Xinzhong Dong; Yihe Hu; Xu Cao
Journal:  Elife       Date:  2020-05-22       Impact factor: 8.140

3.  PGE2/EP4 skeleton interoception activity reduces vertebral endplate porosity and spinal pain with low-dose celecoxib.

Authors:  Peng Xue; Shenyu Wang; Xiao Lyu; Mei Wan; Xialin Li; Lei Ma; Neil C Ford; Yukun Li; Yun Guan; Wenyuan Ding; Xu Cao
Journal:  Bone Res       Date:  2021-08-02       Impact factor: 13.567
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.